PKB-GAMMA (AKT3) (S472) Antikörper

Antigen: PKB-GAMMA (AKT3)

Synonyme: PKBG, PRKBG, STK-2, PKB-GAMMA, RAC-gamma, RAC-PK-gamma, DKFZp434N0250

Epitope: S472

Klonalität: Polyklonal

Wirt: Kaninchen

Reaktivität: Human

Applikation: Dot Blot (Dot), ELISA

Zertifikate: ISO 9001:2008

Produktnummer: ABIN389853

Produktbeschreibung

Produktmerkmale: Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Weitere Bezeichnung: Phospho-AKT3-S472

Gen-ID: 10000

Swiss-Prot: Q9Y243

Immunogen: This Phospho-AKT3-S472 antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding S472 of human AKT3.

Isotyp: Ig  (Passende Sekundärantikörper)

Beschreibung: Other names: RAC-gamma serine/threonine-protein kinase, RAC-PK-gamma, Protein kinase Akt-3, Protein kinase B, gamma, PKB gamma, STK-2, AKT3

Spezifität: This antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding S472 of human AKT3.

Molekulargewicht: 55775 DA

Anwendungen

Applikationshinweise: The suggested dilution is: ELISA ~~ 1:1,000 Dot Blot ~~ 1:500

Konzentration: 0.25 mg/ml

Reinigung: Purified

Buffer: Purified rabbit polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. Then, the antibody fraction is peptide affinity purified in a 2-step procedure with the control and phosphorylated peptides. The phospho-specific antibody is eluted with hi

Lagerung: Maintain refrigerated at 2-8 deg C for up to 6 months. For long term storage store at -20 deg C in small aliquots to prevent freeze-thaw cycles

Forschungsgebiet: Phospho-Antikörper, Zelluläre Signaltransduktion, Proteinmodifikationen, Metabolismus, Zellstruktur

Beschränkungen: Nur für Forschungszwecke einsetzbar

Bilder

Dot blot analysis of anti-AKT3-pS472 Phospho-specific Pab (ABIN389853) on nitrocellulose membrane. 50ng of Phospho-peptide or Non Phospho-peptide per dot were adsorbed. Antibody working concentrations are 0.5ug per ml.

Publikationen

Publikationen: Silva, Garvin: "Akt1 mediates purinergic-dependent NOS3 activation in thick ascending limbs." in: American journal of physiology. Renal physiology, Vol. 297, Issue 3, pp. F646-52, 2009 (PubMed).

Huang, Gonzalez, Toy et al.: "Blockade of CCN6 (WISP3) activates growth factor-independent survival and resistance to anoikis in human mammary epithelial cells." in: Cancer research, Vol. 70, Issue 8, pp. 3340-50, 2010 (PubMed).